Impact of Intermittent Preventive Treatment on Drug-Resistant Malaria
Author Information
Author(s): Prudhomme O'Meara Wendy, Smith David L, McKenzie F. Ellis
Primary Institution: Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America
Hypothesis
How does intermittent preventive treatment (IPT) affect the spread of drug-resistant malaria?
Conclusion
IPT could accelerate the spread of resistant malaria parasites, especially in areas with low or unstable transmission.
Supporting Evidence
- IPT in infants could accelerate the spread of resistant parasites.
- Partially resistant parasites are more likely to spread in low-transmission areas.
- Drugs with longer half-lives increase the risk of resistance development.
Takeaway
Giving malaria drugs to babies who aren't sick might help the parasites become stronger and spread more, especially if the drugs last a long time in their bodies.
Methodology
A mathematical model was used to evaluate the impact of IPT on the spread of drug-resistant malaria.
Limitations
The model's predictions are sensitive to its underlying assumptions and should be used to guide research priorities rather than definitive conclusions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website